Basic Information
LncRNA/CircRNA Name | circ_0067582 |
Synonyms | |
Region | |
Ensemble | |
Refseq |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | NA | Drug | ||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | gastric cancer |
ICD-0-3 | C16 |
Methods | qRT-PCR , immunohistochemical analysis |
Sample | GC tissues and their adjacent non-tumorous tissues |
Expression Pattern | down-regulated |
Function Description | Compared with healthy control tissues, both hsa_circ_0067582 and hsa_circ_0005758 were significantly decreased in GC tissues.Besides, hsa_circ_0067582 expression was associated with GC patients' tissue CEA level and stages; and hsa_circ_0005758 expression was relevant to tissue CEA level and perineural invasion.The area under the ROC curve (AUC) of hsa_circ_0067582 was up to 0.671. The cutoff value was set at 10.61, with which the sensitivity and specificity were 55.2% and 75.1%, respectively. |
Pubmed ID | 31328820 |
Year | 2019 |
Title | Clinical Significances of hsa_circ_0067582 and hsa_circ_0005758 in Gastric Cancer Tissues |
External Links
Links for circ_0067582 | GenBank HGNC NONCODE |
Links for gastric cancer | OMIM COSMIC |